Acadia Healthcare Reports Second Quarter Adjusted EPS of $0.26

Before you go, we thought you'd like these...
Before you go close icon

Acadia Healthcare Reports Second Quarter Adjusted EPS of $0.26

Revenue Totals $177 Million, with 11.2% Growth in Same Facility Revenue

Raises Lower End of 2013 Earnings Guidance to New Range of $1.01 to $1.03


FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (NAS: ACHC) today announced financial results for the second quarter ended June 30, 2013. Revenue was $177.5 million for the second quarter, up 76.6% from $100.5 million for the second quarter of 2012. Income from continuing operations was $12.3 million, or $0.24 per diluted share, for the second quarter of 2013 compared with $6.1 million, or $0.17 per diluted share, for the second quarter of 2012. Adjusted income from continuing operations increased 101.1% to $13.1 million for the second quarter of 2013 from $6.5 million for the second quarter of 2012. The adjusted results exclude transaction-related expenses of $1.4 million and $0.7 million for the second quarter of 2013 and 2012, respectively. Adjusted income from continuing operations per diluted share increased 44.4% to $0.26 for the second quarter of 2013 from $0.18 for the second quarter of 2012, which reflected a 37.0% increase in weighted average shares outstanding for the comparable quarters, primarily due to Acadia's public equity offerings in May 2012 and December 2012. A reconciliation of all GAAP and non-GAAP financial results in this release is on pages 7 and 8.

For the first six months of 2013, revenue increased 78.2% to $338.7 million from $190.1 million for the first six months of 2012. Income from continuing operations was $16.3 million, or $0.33 per diluted share, for the first half of 2013 compared with $9.4 million, or $0.27 per diluted share, for the same period in 2012. Adjusted income from continuing operations increased 130.3% to $23.7 million for the first half of 2013 from $10.3 million for the first half of 2012. The adjusted results for the first half of 2013 exclude debt extinguishment costs of $9.4 million and transaction-related expenses of $2.8 million and, for the first six months of 2012, exclude transaction-related expenses of $1.4 million. Adjusted income from continuing operations per diluted share increased 56.7% to $0.47 for the first six months of 2013 from $0.30 for the comparable period in 2012, which reflected a 45.4% increase in weighted average shares outstanding for the comparable quarters.

"Acadia produced strong profitable growth for the second quarter of 2013," said Joey Jacobs, Chairman and Chief Executive Officer of Acadia. "Our revenue growth was driven by an increase of 1,500 licensed beds to over 3,700 at the end of the latest quarter from approximately 2,200 at the end of the second quarter of 2012. While most of this increase came from our facility acquisitions, we also added approximately 310 beds to existing facilities in the 12 months ended June 30, 2013, as well as opened a 60-bed de novo facility in the latest quarter. In addition to the opening of this facility, we added 152 beds to existing facilities through the first six months of 2013, including 87 beds in the second quarter.

"The addition of new beds in our same facility base, combined with our continuing initiatives in each facility to generate additional revenue, produced same facility revenue growth of 11.2% for the second quarter, reflecting an 8.2% comparable quarter increase in patient days and a 2.7% increase in revenue per patient day. This strong same facility performance generated substantial operating leverage, which was primarily accountable for the 280 basis point expansion in our same facility EBITDA margin for the comparable quarters to 27.5%. Adjusted consolidated EBITDA increased 81.9% to $37.1 million, or 20.9% of consolidated revenue, for the second quarter of 2013 from $20.4 million, or 20.3% of consolidated revenue, for the second quarter of 2012.

"Acadia generated net cash from continuing operations of $27.9 million for the second quarter of 2013 and had cash and cash equivalents of $7.4 million at the quarter's end. We have approximately $100 million of availability under our revolving credit facility and a ratio of total net debt to trailing 12 months adjusted EBITDA, as calculated under our credit agreement, of 4.2 at the end of the quarter. We remain confident of our ability to fund our growth strategies for 2013."

Based on the Acadia's performance for the first half of 2013 and its outlook for the remainder of the year, the Company today raised the lower end of its guidance for 2013 adjusted earnings per diluted share to a new range of $1.01 to $1.03, from $1.00 to $1.03 previously. The Company's guidance does not include transaction-related expenses, debt extinguishment costs and the impact of any future acquisitions.

Acadia will hold a conference call to discuss its second quarter financial results at 9:00 a.m. Eastern Time on Wednesday, July 31, 2013. A live webcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available through August 14, 2013.

Risk Factors

This news release contains forward-looking statements. Generally words such as "may," "will," "should," "could," "anticipate," "expect," "intend," "estimate," "plan," "continue," and "believe" or the negative of or other variation on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this news release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements. Factors that may cause actual results to differ materially include, without limitation, (i) Acadia's ability to complete acquisitions and successfully integrate the operations of the acquired facilities; (ii) Acadia's ability to add beds, expand services, enhance marketing programs and improve efficiencies at its facilities; (iii) potential reductions in payments received by Acadia from the government and third-party payors; (iv) the risk that Acadia may not generate sufficient cash from operations to service its debt and meet its working capital and capital expenditure requirements; and (v) potential operating difficulties, client preferences, changes in competition and general economic or industry conditions that may prevent Acadia from realizing the expected benefits of its business strategy. These factors and others are more fully described in Acadia's periodic reports and other filings with the SEC.

About Acadia

Acadia is a provider of inpatient behavioral healthcare services. Acadia operates a network of 46 behavioral healthcare facilities with over 3,700 licensed beds in 21 states and Puerto Rico. Acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs.

    
Acadia Healthcare Company, Inc.
Consolidated Statements of Operations
(Unaudited)
 
Three Months Ended June 30,Six Months Ended June 30,
2013201220132012
(in thousands, except per share amounts)
 
Revenue before provision for doubtful accounts$182,951$102,752$348,656$194,020
Provision for doubtful accounts (5,457) (2,222) (9,949) (3,927)
Revenue177,494100,530338,707190,093
 
Salaries, wages and benefits (including equity-based compensation expense of $1,812, $592, $2,413 and $1,170, respectively)100,76458,559195,115113,702
Professional fees9,3244,65818,3388,831
Supplies9,6134,87218,2119,317
Rents and leases2,3942,2274,7214,469
Other operating expenses20,09610,40737,07919,388
Depreciation and amortization4,2121,6467,8343,256
Interest expense, net9,4457,47118,20714,753
Debt extinguishment costs--9,350-
Transaction-related expenses 1,355  670  2,829  1,365 
Total expenses 157,203  90,510  311,684  175,081 
Income from continuing operations before income taxes20,29110,02027,02315,012
Provision for income taxes 8,020  3,919  10,698  5,584 
Income from continuing operations12,2716,10116,3259,428
(Loss) income from discontinued operations, net of income taxes (74) (192) (390) 160 
Net income$12,197 $5,909 $15,935 $9,588 
 
Basic earnings per share:
Income from continuing operations$0.24$0.17$0.33$0.27
(Loss) income from discontinued operations -  (0.01) (0.01) 0.01 
Net income$0.24 $0.16 $0.32 $0.28 
 
Diluted earnings per share:
Income from continuing operations$0.24$0.17$0.33$0.27
(Loss) income from discontinued operations -  (0.01) (0.01) 0.01 
Net income$0.24 $0.16 $0.32 $0.28 
 
Weighted-average shares outstanding:
Basic50,00936,50749,96134,313
Diluted50,28236,69550,19634,514
 

  
Acadia Healthcare Company, Inc.
Consolidated Balance Sheets
(Unaudited)
 
June 30, 2013December 31, 2012
(In thousands)
 
ASSETS
Current assets:
Cash and cash equivalents$7,399$49,399

Accounts receivable, net of allowance for doubtful accounts of $11,629 and $7,484, respectively

85,87263,870
Deferred tax assets13,83011,380
Other current assets 19,988  16,332 
Total current assets127,089140,981
Property and equipment, net312,147236,942
Goodwill630,749557,402
Intangible assets, net18,83815,988
Other assets 25,349  32,100 
Total assets$1,114,172 $983,413 
 
 
LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term debt$13,305$7,680
Accounts payable28,07219,081
Accrued salaries and benefits28,13128,749
Other accrued liabilities 17,171  16,341 
Total current liabilities86,67971,851
Long-term debt556,276465,638
Deferred tax liabilities - noncurrent2,267998
Other liabilities 18,110  12,376 
Total liabilities663,332550,863
Equity:
Common stock500499
Additional paid-in capital458,582456,228
Accumulated deficit (8,242) (24,177)
Total equity 450,840  432,550 
Total liabilities and equity$1,114,172 $983,413 
 

 
Acadia Healthcare Company, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
  
Six Months Ended June 30,
20132012
(In thousands)
 
Operating activities:
Net income$15,935$9,588

Adjustments to reconcile net income to net cash provided by continuing operating activities:

Depreciation and amortization7,8343,256
Amortization of debt issuance costs1,1101,224
Equity-based compensation expense2,4131,170
Deferred income tax expense5,3924,854
Loss (income) from discontinued operations, net of taxes390(160)
Debt extinguishment costs9,350-
Other1421
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable(10,557)(6,692)
Other current assets107(2,214)
Other assets(807)313
Accounts payable and other accrued liabilities1,038(2,805)
Accrued salaries and benefits(4,369)327
Other liabilities 458  1,860 
Net cash provided by continuing operating activities28,30810,742
Net cash used in discontinued operating activities (358) (196)
Net cash provided by operating activities27,95010,546
 
Investing activities:
Cash paid for acquisitions, net of cash acquired(121,731)(90,466)
Cash paid for capital expenditures(29,709)(7,619)
Cash paid for real estate acquisitions(3,959 Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners

Gift Finder Promo
More to Explore
Fri, Dec 09
Set Your Location
City, State, or Zip